Biosynth Carbosynth Revenue and Competitors
Estimated Revenue & Valuation
- Biosynth Carbosynth's estimated annual revenue is currently $15M per year.
- Biosynth Carbosynth's estimated revenue per employee is $85,227
Employee Data
- Biosynth Carbosynth has 176 Employees.
- Biosynth Carbosynth grew their employee count by 38% last year.
Biosynth Carbosynth's People
Name | Title | Email/Phone |
---|---|---|
1 | Science Director, Biopolymers | Reveal Email/Phone |
2 | Senior synthetic chemist | Reveal Email/Phone |
3 | Deputy CEO & Head Pharmaceutical and Diagnostic Products | Reveal Email/Phone |
4 | Credit Control Supervisor | Reveal Email/Phone |
Biosynth Carbosynth Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 18 | 20% | N/A | N/A |
#2 | $15M | 176 | 38% | N/A | N/A |
#3 | N/A | 14 | 0% | N/A | N/A |
What Is Biosynth Carbosynth?
Biosynth Carbosynth is the new global brand created from the merger of two key players in the fine chemicals market. We are offering an impressive collection of specialty chemicals and no chemistry is too hard for us ᅢᄁ¬ツᆲ¬タワ if we donᅢᄁ¬ツᆲ¬トᄁt have a compound, weᅢᄁ¬ツᆲ¬トᄁll make it! We are big enough to think and act globally but small enough to be flexible and innovative. WE ARE BIGᅢᄁ¬ツᆲ¬タワ we are the supplier of choice for many institutions in the pharmaceutical, life science, food, agrochemistry, cosmetic and diagnostic sectors. We manufacture and source a vast range of chemical and biochemical products and specialise in carbohydrates, nucleosides, antimicrobials, APIs, enzyme substrates and natural products. Our facilities are based on three continents with manufacturing laboratories in Switzerland, the United Kingdom, Slovakia and China, and distribution centres in the United States. Our R&D resources and production facilities are modern and versatile, allowing us to produce chemicals on a wide scale range ᅢᄁ¬ツᆲ¬タワ from milligrams to tons! WE ARE SMALL ᅢᄁ¬ツᆲ¬タワ we work in small teams with lean and agile management and rapid communication channels. We are flexible and respond quickly and efficiently to customer and market needs. WE ARE INNOVATIVE - we love developing new products and keeping close relationships with our customers and product experts. Ambitious R&D programs lie at the heart of our culture and our research has generated an impressive portfolio of intellectual property such as our AquaSparkᅢᄁ¬ダᅡᄁ product line of novel chemiluminescence. We are chemistry wizards - custom synthesis is a fast-growing part of our business. We have top industry expertise in enzyme substrates, building blocks for organic synthesis as well as carbohydrate and nucleoside chemistry. In addition, quality is our top priority and we operate according to the ISO and GMP quality standards. If you like working in small teams and being able to make a big impact on the business, get in touch with us via our careers page.
keywords:N/AN/A
Total Funding
176
Number of Employees
$15M
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biosynth Carbosynth News
ABCR; Biosynth Carbosynth; Chemwill Asia; Capot Chemical; DAYANG CHEM; Henan Tianfu Chemical; Santa Cruz Biotechnology; Toronto Research Chemicals; TNJ Chemical...
Global Nickel (II) Perchlorate Hexahydrate Market 2022 Key Players Alfa Aesar, Alfa Chemistry, American Elements, Biosynth Carbosynth.
Biosynth Carbosynth; Focus Biomolecules; BroadPharm; APExBIO Technology LLC; MedKoo Biosciences, Inc. Hefei Laman Utama Sunshine Pharmaceutical Technology Co.,...